US Patent 11692021 Compositions comprising PCSK9-binding molecules and methods of use
Article
The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).